Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 3, 2015, Pages 245-249

  Bernstein, Jonathan A ^a   Moellman, Joseph J ^a   Collins, Sean P ^b   Hart, Kimberly W ^a   Lindsell, Chris J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECALLANTIDE; PLACEBO; BRADYKININ; KALLIKREIN; PEPTIDE;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; STOMACH PAIN; SUPRAVENTRICULAR TACHYCARDIA; THORAX PAIN; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ANGIOEDEMA; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EMERGENCY HEALTH SERVICE; MIDDLE AGED;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; DOUBLE-BLIND METHOD; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; PEPTIDES; PLACEBOS;

EID: 84924608839     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.12.007     Document Type: Article

References (34)

1. J.A. Bernstein, and J. Moellman Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema Int J Emerg Med 5 2012 39
2. J.A. Bernstein, and J.J. Moellman Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States Postgrad Med 124 2012 91 100
3. J.J. Moellman, and J.A. Bernstein Diagnosis and management of hereditary angioedema: an emergency medicine perspective J Emerg Med 43 2012 391 400
4. B. Boyang, C.M.L. Kelton, J.J. Guo, and P.R. Wigle ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008 J Manag Care Pharm 16 2010 671 679
5. J.B. Kostis, H.J. Kim, and J. Rusnak Incidence and characteristics of angioedema associated with enalapril Arch Intern Med 165 2005 1637 1642
6. D.R. Miller, S.A. Oliveria, D.R. Berlowitz, B.G. Fincke, P. Stang, and D.E. Lillienfeld Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors Hypertension 51 2008 1624 1630
7. B.L. Zuraw, J.A. Bernstein, and D. Lang A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and ACE inhibitor associated angioedema J Allergy Clin Immunol 131 2013 1491 1493 3e1-3e25
8. A. Banerji, S. Clark, M. Blanda, F. LoVecchio, B. Snyder, and C.A. Camargo Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department Ann Allergy Asthma Immunol 100 2008 327 332
9. A. Banerji, E. Oren, P. Hesterberg, Y. Hsu, C.A. Camargo Jr., and J.T. Wong Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult service Allergy Asthma Proc 29 2008 88 92
10. V. Bafunno, C. Divella, and F. Sessa De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema J Allergy Clin Immunol 132 2013 748 750 e3
11. A. Lopez-Lera, B. Favier, R.M. de la Cruz, S. Garrido, C. Drouet, and M. Lopez-Trascasa A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation J Allergy Clin Immunol 126 2010 1307 1310 e3
12. E. Pappalardo, M. Cicardi, and C. Duponchel Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema J Allergy Clin Immunol 106 2000 1147 1154
13. O. Roche, A. Blanch, C. Duponchel, G. Fontan, M. Tosi, and M. Lopez-Trascasa Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort Hum Mutat 26 2005 135 144
14. P. Campo, T.D. Fernandez, G. Canto, and C. Mayorga Angioedema induced by angiotensin-converting enzyme inhibitors Curr Opin Allergy Clin Immunol 13 2013 337 344
15. A. Adam, M. Cugno, G. Molinaro, M. Perez, Y. Lepage, and A. Agostoni Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors Lancet 359 2002 2088 2089
16. C. Blais Jr., J.L. Rouleau, and N.J. Brown Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema Immunopharmacology 43 1999 293 302
17. D.G. Burkhart, N.J. Brown, M.R. Griffin, W.A. Ray, T. Hammerstrom, and S. Weiss Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites Pharmacoepidemiol Drug Saf 5 1996 149 154
18. J.B. Byrd, K. Touzin, and S. Sile Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema Hypertension 51 2008 141 147
19. A.L. Cilia La Corte, A.M. Carter, and G.I. Rice A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema Hum Mutat 32 2011 1326 1331
20. Q.L. Duan, B. Nikpoor, and M.P. Dube A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors Am J Hum Genet 77 2005 617 626
21. J.B. Byrd, A. Adam, and N.J. Brown Angiotensin-converting enzyme inhibitor-associated angioedema Immunol Allergy Clin North Am 26 2006 725 737
22. J.A. Bernstein, and J. Biedenkapp Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency Clin Invest 3 2013 859 873
23. E. Ishoo, U.K. Shah, G.A. Grillone, J.R. Stram, and N.S. Fuleihan Predicting airway risk in angioedema: staging system based on presentation Otolaryngol Head Neck Surg 121 1999 263 268
24. B.C. Benson, C. Smith, and J.T. Laczek Angiotensin converting enzyme inhibitor-induced gastrointestinal angioedema: a case series and literature review J Clin Gastroenterol 47 2013 844 849
25. N.J. Brown, M. Snowden, and M.R. Griffin Recurrent angiotensin-converting enzyme inhibitor-associated angioedema JAMA 278 1997 232 233
26. C. Cupido, and B. Rayner Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril S Afr Med J 97 2007 244 245
27. D.E. Dean, D.L. Schultz, and R.H. Powers Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease J Forensic Sci 46 2001 1239 1243
28. E.E. Slater, D.D. Merrill, and H.A. Guess Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition JAMA 260 1988 967 970
29. H.M. Bluestein, T.A. Hoover, A.S. Banerji, C.A. Camargo Jr., A. Reshef, and P. Herscu Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department Ann Allergy Asthma Immunol 103 2009 502 507
30. J.J. Moellman, J.A. Bernstein, and C. Lindsell A consensus parameter for the evaluation and management of angioedema in the emergency department Acad Emerg Med 21 2014 469 484
31. B. Malde, J. Regalado, and P.A. Greenberger Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers Ann Allergy Asthma Immunol 98 2007 57 63
32. A. Bygum Hereditary angio-oedema in Denmark: a nationwide survey Br J Dermatol 161 2009 1153 1158
33. C. Gang, C.J. Lindsell, and J. Moellman Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema Allergy Asthma Proc 34 2013 267 273
34. Lewis LM, Graffeo C, Crosley P, et al. Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial [published ahead of print August 30, 2014]. Ann Emerg Med. http://dx.doi.org/10.1016/j.annemergmed.2014.07.014.